Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Crowdsourced RNA design discovers diverse, reversible, efficient, self-contained molecular switches.
Andreasson JOL, Gotrik MR, Wu MJ, Wayment-Steele HK, Kladwang W, Portela F, Wellington-Oguri R; Eterna Participants; Das R, Greenleaf WJ. Andreasson JOL, et al. Among authors: portela f. Proc Natl Acad Sci U S A. 2022 May 3;119(18):e2112979119. doi: 10.1073/pnas.2112979119. Epub 2022 Apr 26. Proc Natl Acad Sci U S A. 2022. PMID: 35471911 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927-5. Online ahead of print. Lancet. 2024. PMID: 39706209
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes.
Magalhaes D, Santiago M, Patita M, Arroja B, Lago P, Rosa I, Sousa HT, Ministro P, Mocanu I, Vieira A, Castela J, Moleiro J, Roseira J, Eugenia C, Sousa P, Portela F, Correia L, Dias S, Afonso J, Danese S, Peyrin-Biroulet L, Dias CC, Magro F; GEDII. Magalhaes D, et al. Among authors: portela f. United European Gastroenterol J. 2024 Dec 8. doi: 10.1002/ueg2.12712. Online ahead of print. United European Gastroenterol J. 2024. PMID: 39648597 Free article.
Plasma calprotectin as a biomarker of inflammatory activity in ulcerative colitis.
Temido MJ, Peixinho M, Cunha R, Silva A, Lopes S, Mendes S, Ferreira AM, Ferreira M, Figueiredo P, Portela F. Temido MJ, et al. Among authors: portela f. Med Clin (Barc). 2024 Nov 15:S0025-7753(24)00597-9. doi: 10.1016/j.medcli.2024.09.009. Online ahead of print. Med Clin (Barc). 2024. PMID: 39550244 English, Spanish.
High-intensity interval training alleviates liver inflammation by regulating the TLR4/NF-κB signaling pathway and M1/M2 macrophage balance in female rats with cisplatin hepatotoxicity.
Malheiro LFL, Oliveira CA, Portela FS, Mercês ÉAB, Benedictis LM, Benedictis JM, Andrade EN, Magalhães ACM, Melo FF, Oliveira PDS, Soares TJ, Amaral LSB. Malheiro LFL, et al. Among authors: portela fs. Biochem Biophys Res Commun. 2024 Nov 12;733:150712. doi: 10.1016/j.bbrc.2024.150712. Epub 2024 Sep 17. Biochem Biophys Res Commun. 2024. PMID: 39317112
Mycofenolate-induced ileocolitis.
Silva A, Madeira J, Lopes S, Silva MR, Portela F, Figueiredo P. Silva A, et al. Among authors: portela f. Rev Esp Enferm Dig. 2024 Sep 13. doi: 10.17235/reed.2024.10713/2024. Online ahead of print. Rev Esp Enferm Dig. 2024. PMID: 39267473 Free article.
197 results